Paladin Pharma Overview
- Year Founded
-
1983

- Status
-
Acquired/Merged
- Employees
-
403

- Latest Deal Type
-
M&A
- (Announced)
- Financing Rounds
-
5
- Investments
-
17
Paladin Pharma General Information
Description
Operator of a specialty pharmaceutical company intended for the Canadian and other international markets. The company is focused on developing, acquiring, in-licensing, and commercializing pharmaceutical products, delivering medicines to patients through development, manufacturing and commercialization.
Contact Information
Website
www.paladin-pharma.com(Operating Subsidiary)
Corporate Office
- 100 Boulevard Alexis-Nihon
- Suite 600
- Saint-Laurent, Quebec H4M 2P2
- Canada
Corporate Office
- 100 Boulevard Alexis-Nihon
- Suite 600
- Saint-Laurent, Quebec H4M 2P2
- Canada
Paladin Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Paladin Pharma Comparisons
Industry
Financing
Details
Paladin Pharma Competitors (2)
One of Paladin Pharma’s 2 competitors is Knight Therapeutics, a Corporation company based in Montreal, Canada.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Knight Therapeutics | Corporation | Montreal, Canada | ||||
Acerus Pharmaceuticals | Corporation | Mississauga, Canada |
Paladin Pharma Patents
Paladin Pharma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-2797098-A1 | Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof | Active | 23-Apr-2010 | ||
EP-2563349-A1 | Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof | Inactive | 23-Apr-2010 | ||
JP-2017186346-A | Non-intravenous dosage form comprising solid formulation of liquid biologically active component and uses thereof | Active | 23-Apr-2010 | ||
EP-2563349-A4 | Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof | Inactive | 23-Apr-2010 | ||
CA-2797098-C | Non-intravenous dosage form comprising solid formulation of liquid biologically active agent and uses thereof | Active | 23-Apr-2010 | A61K31/05 |
Paladin Pharma Signals
Paladin Pharma Investments & Acquisitions (17)
Paladin Pharma’s most recent deal was a Seed Round with Change Donations for . The deal was made on 01-Feb-2020.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Change Donations | 01-Feb-2020 | Seed Round | Financial Software | ||
Litha Healthcare Group | 15-Oct-2014 | Secondary Transaction - Private | Distributors (Healthcare) | ||
Triton Pharma | 13-Jan-2014 | Merger/Acquisition | Pharmaceuticals | ||
Litha Healthcare Group | 30-Sep-2013 | Merger/Acquisition | Distributors (Healthcare) | ||
Allon Therapeutics | 16-Jul-2013 | Merger/Acquisition | Biotechnology |
Paladin Pharma Exits (6)
Paladin Pharma’s most recent exit was on 15-Oct-2014 from Litha Healthcare Group. The exit was categorized as .
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
Litha Healthcare Group | 15-Oct-2014 | Completed |
|
||
Litha Healthcare Group | 30-Sep-2013 | Completed |
|
||
Telesta Therapeutics | 06-Jun-2013 | Completed |
|
||
Litha Healthcare Group | 21-Feb-2012 | Completed |
|
||
Afexa Life Sciences | 15-Jul-2011 | Secondary Transaction - Open Market | Completed |
Paladin Pharma FAQs
-
When was Paladin Pharma founded?
Paladin Pharma was founded in 1983.
-
Where is Paladin Pharma headquartered?
Paladin Pharma is headquartered in Saint-Laurent, Canada.
-
What is the size of Paladin Pharma?
Paladin Pharma has 403 total employees.
-
What industry is Paladin Pharma in?
Paladin Pharma’s primary industry is Pharmaceuticals.
-
Is Paladin Pharma a private or public company?
Paladin Pharma is a Private company.
-
What is the current valuation of Paladin Pharma?
The current valuation of Paladin Pharma is
. -
What is Paladin Pharma’s current revenue?
The current revenue for Paladin Pharma is
. -
How much funding has Paladin Pharma raised over time?
Paladin Pharma has raised $13.9M.
-
Who are Paladin Pharma’s competitors?
Knight Therapeutics and Acerus Pharmaceuticals are competitors of Paladin Pharma.
-
When was Paladin Pharma acquired?
Paladin Pharma was acquired on 11-Mar-2025.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »